Compare Bristol-Myers Squibb Co (BMY) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs NextEra Energy, Inc. — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while NextEra Energy, Inc. trades at $85.74 (market cap $178.85B). The key difference: NextEra Energy, Inc. is the larger of the two by market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | NEE | |
|---|---|---|
Market Cap | $129.94B | $178.85B |
Sector | Health | Utilities |
52-Week High | $65.89 | $97.88 |
52-Week Low | $42.60 | $69.77 |
Enterprise Value | $163.92B | $286.18B |
Dividend Yield | 3.96% | 2.91% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
